Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism

NCT00776191 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped al study sites stoped on 15/05/2012 because of insufficient recrutement.

Conditions

Endstage Renal Disease

Interventions

DRUG: Physioneal 35
DRUG: Physioneal 40

Sponsor

University of Erlangen-Nürnberg Medical School